Synergistic effect of D-003 and aspirin on experimental thrombosis models

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 68, Issue 5, 2003, Pages 305-310

  Molina, V ^a   Arruzazabala, M L ^a   Carbajal, D ^a   Mas R ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; D 003; NATURAL PRODUCT; POLICOSANOL; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ENZYME INHIBITION; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SINGLE DRUG DOSE; SUDDEN DEATH; SUGARCANE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS;

SACCHARUM HYBRID CULTIVAR;

EID: 0037733976     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(03)00020-6     Document Type: Article

References (49)

1. J.M. Wilson, J.J. Ferguson, Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications, Clin. Cardiol. 22 (11) (1999) 687-698.
2. M. Cattaneo, Antiplatelet Trialists'Collaboration, Secondary prevention of vascular events by prolonged antiplatelet therapy, Br. Med. J. 296 (1988) 320-331.
3. M. Basista, J. Dobranowski, R.J. Gryglewski, Prostacyclin and thromboxane generating systems in rabbits pretreated with aspirin, Pharmacol. Res. Commun. 10 (1978) 759-763.
4. B.B. Vargaftig, The inhibition of cyclooxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines, Eur. J. Pharmacol. 50 (1978) 231-241.
5. J. Merino, M. Livio, G. Rajtar, G. de Caetano, Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation, Biochem. Pharmacol. 29 (1980) 293-297.
6. L. Gonzalez, D. Marrero, A. Laguna, R. Más, M.L. Arruzazabala, D. Carbajal, M. Cora, R. Menéndez, A mixture of primary fatty acids obtained from sugar cane wax, WO 98/43631, 1998.
7. R. Gámez, S. Mendoza, R. Más, R. Mesa, G. Castaño, D. Marrero, Dose-dependent cholesterol-lowering effects of D-003 on normocholesterolemic rabbits, Curr. Ther. Res. 61 (2000) 8-16.
8. V. Molina, M.L. Arruzazabala, D. Carbajal, R. Más, S. Valdés, Antiplatelet and antithrombotic effects of D-003, Pharmacol. Res. 42 (2) (2000) 137-143.
9. A. Laguna, J. Magraner, D. Carbajal, M.L. Arruzazabala, R. Más, M. Garcia, A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses, USA Patent 5.663.156, 1997.
10. M.L. Arruzazabala, D. Carbajal, R. Más, M. García, V. Fraga, Effects of policosanol on platelet aggregation in rats, Thromb. Res. 69 (1993) 321.
11. M.L. Arruzazabala, D. Carbajal, V. Molina, et al., Estudio farmacologico de la interaccin entre el policosanol y la aspirina en animales de experimentacion, Rev. Iberoamer. Tromb. Hemost. 5 (1992) 17-20.
12. 2, Prostaglandins Leukot. Essent. Fatty Acids 49 (1993) 695-697.
13. D. Carbajal, M.L. Arruzazabala, R. Más, V. Molina, S. Valdés, Effect of policosanol on experimental thrombosis models, Prostaglandins Leukot. Essent. Fatty Acids 50 (1994) 249.
14. S. Valdés, M.L. Arruzazabala, L. Fernández, et al., Effect of policosanol on platelet aggregation in healthy volunteers, Int. J. Clin. Pharmacol. Res. XVI (2/3) (1996) 67-72.
15. M.L. Arruzazabala, S. Valdés, R. Más, D. Carbajal, L. Fernández, Comparative study of policosanol, aspirin and the combination therapy policosanol-aspirin on platelet aggregation in healthy volunteers, Pharmacol. Res. 36 (4) (1997).
16. D. Carbajal, M.L. Arruzazabala, S. Valdés, R. Más, Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers, Prostaglandins Leukot. Essent. Fatty Acids 58 (1998) 61-64.
17. M.L. Arruzazabala, R. Más, V. Molina, D. Carbajal, S. Mendoza, L. Fernández, S. Valdés, Effect of policosanol on platelet aggregation in type II hypercholesterolemic patients, Int J. Tissue Reactions XX (4) (1998) 57-62.
18. E. Rizzo, D. Craft, A. Dammann, M. Phillip, Fatty alcohol metabolism in cultured fibroblasts. Evidence for a fatty alcohol cycle, J. Clin. Chem. 262 (1990) 17412-17419.
19. Y. Kabir, S. Kimura, Biodistribution and metabolism of orally administered octacosanol in rats, Ann. Nutr. Metab. 37 (1993) 33-38.
20. Y. Kabir, S. Kimura, Tissue distribution of (8-14C)-octacosanol in liver and muscle of rats after serial administration, Ann. Nutr. Metab. 39 (1995) 279-284.
21. Y. Kabir, S. Kimura, Metabolism of octacosanol in liver and muscle of rat, Acta Aliment. 24 (1) (1995) 39-46.
22. D. Del Principe, A. Menichelli, W. De Matteis, M.L. Di Corpo, S. Di Giulio, A.F. Finazzi-Agro, Hydrogen peroxide has a role in the aggregation of human platelets, FEBS Lett. 1 (1985) 42.
23. L. Iuliano, A.R. Colavita, R. Leo, D. Pratico, F. Violi, Oxygen free radicals and platelet activation, Free Radical Biol. Med. 22 (1997) 999.
24. V. Fraga, R. Menendez, A.M. Amor, R.M. Gonzalez, S. Jimenez, R. Mas, Effect of policosanol on in vitro and in vivo rat liver microsomal lipid peroxidation, Arch. Med. Res. 28 (1997) 355-360.
25. R. Menéndez, R. Más, A.M. Amor, N. Ledón, Y. Pérez, R.M. González, I. Rodeiro, M. Zayas, S. Jiménez, Inhibition of rats lipoprotein lipid peroxidation by the oral administration of D-003, a mixture of very long chain saturated fatty acids, Can. J. Physiol. Pharmacol. 12 (2001) 1-8.
26. R. Más, Policosanol, Drugs Future 25 (2000) 569-586.
27. R.B. Philp, M.L. Paul, J.J. Killackey, B.A. Killackey, The influence of dose, time of administration, body temperature and salicylate kitetics on the antithrombotic action of acetylsalicylic acid in male rats, Haemostasis 13 (1983) 42.
28. C. Davison, Salicylate metabolism in man, Ann. NY Acad. Sci. 179 (1971) 249-268.
29. P.W. Majerus, Arachidonate metabolism in vascular disorders, J. Clin. Invest. 72 (1983) 1521-1525.
30. E. Dejana, S. Villa, G. Gaetano, Bleeding time in rats: a comparison of different experimental conditions, Thromb. Haemost. 48 (1982) 108.
31. C. Kohler, W. Wooding, L. Ellenbogen, Intravenous arachidonate in the mouse: a model for the evaluation of anti-thrombotic drugs, Thromb. Res. 9 (1976) 67-80.
32. V. Molina, M.L. Arruzazabala, D. Carbajal, R. Más, D-003, a potential antithrombotic compound isolated from sugar cane wax with effects on arachidonic acid metabolites, Prostaglandins Leukot. Essent. Fatty Acids 67 (2002) 19-24.
33. H. Darius, A. Lefer, Blockade of thromboxane and the prevention of eicosanoid-induced sudden death in mice, Proc. Soc. Exp. Biol. Med. 180 (1985) 364-368.
34. E. Bassenge, Endothelial function in different organs, Progr. Cardiovasc. Dis. XXXiX (1996) 209-228.
35. S. Moncada, R.J. Gryglewski, S. Bunting, J.R. Vane, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation, Nature 263 (1976) 663-665.
36. K.K. Hampton, C. Cerletti, L.A. Loizou, F. Bucchi, M.B. Donati, J.A. Davies, G. de Gaetano, C.R. Prentice, Coagulation, fibrinolytic and platelet function in patients on long term therapy with aspirin 300 mg or 1,2 mg daily compared with placebo, Thromb. Haemost. 64 (1) (1990) 17-20.
37. G.A. FitzGerald, J.A. Oates, J. Hawiger, R.L. Maas, L.J. Roberts, J.A. Lawson, A.R. Brash, Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man, J. Clin. Invest. 71 (1988) 676-688.
38. G.H.R. Rao, J.G. White, Influence of various doses of aspirin (in vivo) on platelet arachidonic acid metabolism (ex vivo) and function, Prostaglandins Leukot. Essent. Fatty Acids 51 (1994) 63-67.
39. M. Janes, J. Walsh, Effect of aspirin and alcohol on platelet and vascular prostacyclin synthesis, Thromb. Res. 39 (1985) 587-593.
40. M.J. Silver, W. Hoch, J.J. Kocsis, C.M. Ingerman, J.B. Smith, Arachidonic acid causes sudden death in rabbits, Science (Washington, DC) 183 (1974) 1085-1087.
41. J.B. Smith, The prostanoids in hemostasis and thrombosis, Am. J. Pathol. 99 (1980) 743-804.
42. A.M. Lefer, S.E. Burke, J.B. Smith, Role of thromboxanes and prostaglandin endoperoxides in the pathogenesis of eicosanoid induced sudden death, Thromb. Res. 32 (1983) 311-320.
43. A. Myers, J. Penhos, E. Ramey, P. Ramwell, Thromboxane agonism and antagonism in a mouse sudden death model, J. Pharmacol. Exp. Ther. 224 (1983) 369-372.
44. G. Di Pasquale, D. Mellace, Inhibition of arachidonic acid induced mortality in rabbits with several non-steroidal anti-inflammatory agents, Agents Actions 7 (1977) 481-485.
45. L.J. Kuster, J.C. Frolich, Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet activating factor following low dose acetylsalicylic acid in man, Prostaglandins 32 (1986) 415-423.
46. L.C. Edmonds, A.M. Lefer, Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death, Life Sci. 35 (1984) 1763-1768.
47. R.R. Makkar, N.L. Eigler, S. Kaul, A. Frimerman, M. Nakamura, P.K. Shah, J.S. Forrester, J.M. Herbert, F. Litvack, Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis, Eur. Heart J. 19 (10) (1998) 1538-1546.
48. J.M. Herbert, F. Dol, A. Bernat, R. Falotico, A. Lale, P. Savi, The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit, Thromb. Haemost. 80 (3) (1998) 512-518.
49. E.V. Negrescu, B. Grunberg, M.A. Kratzer, R. Lorenz, W. Siess, Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside, Cardiovasc. Drugs Ther. 9 (4) (1995) 619-629.